GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSTO:BGBIOO) » Definitions » Days Sales Outstanding

BerGenBio ASA (OSTO:BGBIOO) Days Sales Outstanding : 0.00 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Days Sales Outstanding?

BerGenBio ASA's average Accounts Receivable for the three months ended in Dec. 2023 was kr0.00 Mil. BerGenBio ASA's Revenue for the three months ended in Dec. 2023 was kr0.35 Mil. Hence, BerGenBio ASA's Days Sales Outstanding for the three months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for BerGenBio ASA's Days Sales Outstanding or its related term are showing as below:

OSTO:BGBIOO's Days Sales Outstanding is not ranked *
in the Biotechnology industry.
Industry Median: 72.19
* Ranked among companies with meaningful Days Sales Outstanding only.

BerGenBio ASA's Days Sales Outstanding stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).


BerGenBio ASA Days Sales Outstanding Historical Data

The historical data trend for BerGenBio ASA's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Days Sales Outstanding Chart

BerGenBio ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only - - - - -

BerGenBio ASA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BerGenBio ASA's Days Sales Outstanding

For the Biotechnology subindustry, BerGenBio ASA's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BerGenBio ASA's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BerGenBio ASA's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where BerGenBio ASA's Days Sales Outstanding falls into.



BerGenBio ASA Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

BerGenBio ASA's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0.354*365
=0 / 0.354*365
=0.00

BerGenBio ASA's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0.354*365 / 4
=0 / 0.354*365 / 4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BerGenBio ASA  (OSTO:BGBIOO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


BerGenBio ASA Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


BerGenBio ASA (OSTO:BGBIOO) Business Description

Traded in Other Exchanges
Address
Mollendalsbakken 9, Bergen, NOR, 5009
BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is d is curently being developed in STK11 mutated NSCLC and severe respiratory infections including COVID-19. .

BerGenBio ASA (OSTO:BGBIOO) Headlines

No Headlines